SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-22-003680
Filing Date
2022-05-13
Accepted
2022-05-13 15:01:14
Documents
13
Period of Report
2022-05-11
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_051322.htm   iXBRL 8-K 26244
2 EXHIBIT 16.1 exh_161.htm EX-16.1 1983
  Complete submission text file 0001171843-22-003680.txt   197596

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE xbit-20220511.xsd EX-101.SCH 2959
4 XBRL LABEL FILE xbit-20220511_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE xbit-20220511_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_051322_htm.xml XML 3337
Mailing Address 5217 WINNEBAGO LANE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37347 | Film No.: 22922096
SIC: 2834 Pharmaceutical Preparations